Dante Rotili

Pubblicazioni

Titolo Pubblicato in Anno
First-in-Class Inhibitors of the Ribosomal Oxygenase MINA53 JOURNAL OF MEDICINAL CHEMISTRY 2021
JQ1, inibitore delle proteine BET, riduce i fattori di virulenza e la patogenicità di Aspergillus fumigatus. 13° Congresso Nazionale della Società Italiana di Microbiologia Farmaceutica Obiettivi e Sfide della Microbiologia Moderna per la Difesa della Salute 2021
Mass spectrometry enables the discovery of inhibitors of an LPS transport assembly via disruption of protein-protein interactions CHEMICAL COMMUNICATIONS 2021
Emerging Therapeutic Potential of SIRT6 Modulators JOURNAL OF MEDICINAL CHEMISTRY 2021
Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression GASTROENTEROLOGY 2021
Tranylcypromine-based LSD1 inhibitors: structure-activity relationships, antiproliferative effects in leukemia, and gene target modulation CHEMMEDCHEM 2020
Sirtuin modulators: where are we now? A review of patents from 2015 to 2019 EXPERT OPINION ON THERAPEUTIC PATENTS 2020
Radioguided surgery with β− radiation in pancreatic Neuroendocrine tumors: a feasibility study SCIENTIFIC REPORTS 2020
From parp1 to tnks2 Inhibition: a structure-based approach ACS MEDICINAL CHEMISTRY LETTERS 2020
Identification of Inhibitors to trypanosoma cruzi sirtuins based on compounds developed to human enzymes INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020
The pan-sirtuin inhibitor MC2494 regulates mitochondrial function in a leukemia cell line FRONTIERS IN ONCOLOGY 2020
Sirt4: a multifaceted enzyme at the crossroads of mitochondrial metabolism and cancer FRONTIERS IN ONCOLOGY 2020
Targeting histone acetylation/deacetylation in parasites: an update (2017–2020) CURRENT OPINION IN CHEMICAL BIOLOGY 2020
Characterization of water-soluble esters of nitrobenzoxadiazole-based GSTP1-1 inhibitors for cancer treatment BIOCHEMICAL PHARMACOLOGY 2020
Pharmacological inhibition of lysine-specific demethylase 1 (LSD1) induces global transcriptional deregulation and ultrastructural alterations that impair viability in Schistosoma mansoni PLOS NEGLECTED TROPICAL DISEASES 2020
CDK9 as a valuable target in cancer: from natural compounds inhibitors to current treatment in pediatric soft tissue sarcomas FRONTIERS IN PHARMACOLOGY 2020
Recent advances in epigenetic proteolysis targeting chimeras (Epi-PROTACs) EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2020
HAT inhibitors in cancer therapy Histone Modifications in Therapy 2020
Lysine Acetyltransferase Inhibitors From Natural Sources FRONTIERS IN PHARMACOLOGY 2020
Identification of novel quinazoline derivatives as potent antiplasmodial agents EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 2019

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma